Licensed Anti-Microbial Drugs Logical for Clinical Trials against Pathogens Currently Suspected in Alzheimer’s Disease

There is now considerable evidence that several infectious agents (viruses, bacteria, or parasites) may play a contributing role in the development of Alzheimer’s disease (AD). The six primary suspects are herpes viruses, spirochetal Chlamydia pneumoniae, Porphyromonas gingivalis, mycobacteria, and toxoplasma parasites. Also, some antimicrobial antiviral used to treat them have shown promise for AD interventions. I describe this assert it time accelerate clinical trials these existing drugs, already federally approved, determine if such treatments can delay, halt, reverse AD.